title: A cost-effectiveness analysis of India's 2008 prohibition of smoking in public places in Gujarat.
abstract: Tobacco smoking and exposure to secondhand tobacco smoke are associated with disability and premature mortality in low and middle-income countries. The aim of this study was to assess the cost-effectiveness of implementing India's Prohibition of Smoking in Public Places Rules in the state of Gujarat, compared to implementation of a complete smoking ban. Using standard cost-effectiveness analysis methods, the cost of implementing the alternatives was evaluated against the years of life saved and cases of acute myocardial infarction averted by reductions in smoking prevalence and secondhand smoke exposure. After one year, it is estimated that a complete smoking ban in Gujarat would avert 17,000 additional heart attacks and gain 438,000 life years (LY). A complete ban is highly cost-effective when key variables including legislation effectiveness were varied in the sensitivity analyses. Without including medical treatment costs averted, the cost-effectiveness ratio ranges from $2 to $112 per LY gained and $37 to $386 per acute myocardial infarction averted. Implementing a complete smoking ban would be a cost saving alternative to the current partial legislation in terms of reducing tobacco-attributable disease in Gujarat.
authors.affiliation: Institute for Global Tobacco Control, Johns Hopkins Bloomberg School of Public Health, 627 N Washington Street, 2nd Floor, Baltimore, MD 21205, USA. edonalds@jhsph.edu
authors.forename: Elisabeth A
authors.initials: EA
authors.lastname: Donaldson
authors.forename: Hugh R
authors.initials: HR
authors.lastname: Waters
authors.forename: Monika
authors.initials: M
authors.lastname: Arora
authors.forename: Beena
authors.initials: B
authors.lastname: Varghese
authors.forename: Paresh
authors.initials: P
authors.lastname: Dave
authors.forename: Bhavesh
authors.initials: B
authors.lastname: Modi
mesh_terms: D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D007194:India / Q000453:epidemiology; D008297:Male; D009203:Myocardial Infarction / Q000517:prevention & control; D015995:Prevalence; D011640:Public Policy / Q000191:economics; D012907:Smoking / Q000191:economics / Q000453:epidemiology / Q000331:legislation & jurisprudence*